ESC Premium Access

Effects of the glucagon like peptide-1 receptor analogue, sodium-glucose co-transporter 2 and their combination on myocardial work index and vascular function in diabetes after 3-month treatment

Congress Presentation

About the speaker

Doctor Ignatios Ikonomidis

National & Kapodistrian University of Athens, Athens (Greece)
5 presentations

6 more presentations in this session

Beta-blockers in diabetes with stable coronary heart disease- a cause for concern?

Speaker: Assistant Professor A. Malik (Valhalla, US)


Peripheral neuropathy and diastolic function are associated with adverse cardiovascular outcome in patients with type 1 diabetes mellitus: results from the thousand & 1 study

Speaker: Doctor M. Jensen (Copenhagen, DK)


Heterogeneity of treatment effects from an intensive lifestyle weight loss intervention on cardiovascular events in patients with type 2 diabetes: data from the Look AHEAD trial.

Speaker: Miss T. de Vries (Utrecht, NL)


The ceramide-based Coronary Event Risk Test (CERT) predicts cardiovascular mortality in cardiovascular disease patients with type 2 diabetes mellitus as well as in those without diabetes

Speaker: Doctor A. Mader (Feldkirch, AT)


Tissue sodium concentration emerged as a determinant of hypertrophic vascular remodeling in type 2 diabetes

Speaker: Miss S. Jung (Erlangen, DE)


Access the full session

Diabetes and the heart

Speakers: Doctor I. Ikonomidis, Assistant Professor A. Malik, Doctor M. Jensen, Miss T. de Vries, Doctor A. Mader...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb